Finance

Lists
Why is 603538 down 2.20%?
Dive Deeper
603538:SHA
Ningbo Menovo Pharmaceutical Co Ltd
CNÂ¥19.14
-2.20%
(-0.43) 1D
Nov 17, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603538...
Open
CNÂ¥19.27
High
CNÂ¥19.81
Low
CNÂ¥18.95
Mkt. cap
6.65B
Avg. vol.
33.02M
Volume
14.02M
Dividend
0.58%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 9, 2026
P/E ratio
58.16
52-wk high
CNÂ¥50.28
52-wk low
CNÂ¥13.55
EPS
CNÂ¥0.33
Shares outstanding
149.13M
No. of employees
2K
Open
CNÂ¥19.27
High
CNÂ¥19.81
Low
CNÂ¥18.95
Mkt. cap
6.65B
Avg. vol.
33.02M
Volume
14.02M
Dividend
0.58%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 9, 2026
P/E ratio
58.16
52-wk high
CNÂ¥50.28
52-wk low
CNÂ¥13.55
EPS
CNÂ¥0.33
Shares outstanding
149.13M
No. of employees
2K
News stories
From web sources and news partners
About Ningbo Menovo Pharmaceutical Co Ltd
CEO-
Employees2.37K
FoundedFeb 19, 2004
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
386.33M
337.65M
521.17M
581.89M
Cost of goods sold
264.93M
246.07M
358.46M
442.57M
Cost of revenue
264.93M
246.07M
358.46M
442.57M
Research and development expenses
45.05M
9.59M
29.20M
32.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.07M
43.79M
52.68M
60.93M
Operating expense
122.37M
47.60M
93.06M
85.86M
Total operating expenses
387.30M
293.67M
451.52M
528.43M
Operating income
-974.95K
43.98M
69.65M
53.45M
Other non operating income
-4.04M
-9.70M
6.71M
-25.02M
EBT including unusual items
11.60M
37.14M
53.22M
43.74M
EBT excluding unusual items
-14.36M
35.96M
61.02M
48.63M
Income tax expense
6.62M
4.67M
20.10M
3.41M
Effective tax rate
57.06%
12.57%
37.77%
7.79%
Other operating expenses
14.54M
-3.13M
4.72M
-7.91M
Net income
6.30M
31.16M
32.53M
40.43M
Net profit margin
1.63%
9.23%
6.24%
6.95%
Earnings per share
-
-
-
-
Interest and investment income
-
12.36M
3.20M
6.39M
Interest expense
-5.68M
-10.67M
-1.88M
-2.86M
Net interest expenses
-5.68M
1.68M
1.33M
3.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.08M
77.03M
104.33M
86.51M
Gain or loss from assets sale
142.66K
-
1.02M
-1.02M
Upcoming events
AI content may include mistakes. Learn more
Google apps